On the principle that a stopped clock can at least tell the right time twice a day, we can be confident the sharemarket has at some point in the last few years offered a reasonable valuation of biotech company Pacific Edge.
In March 2020 the shares were worth 7c, valuing the company at $48.3
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
